Grant Erdel

Registered Lobbyist

Disclosed Prior Positions

Senator Christopher Bond - Legislative Correspondent Representative Jo Ann Emerson - Administration Assistant Representative Charles Bass - SeniorPolicy Advisor

Legislative Correspondent - Senator Bond Administrative Assistant - Representative Jo Ann Emerson Senior Policy Advisor - Representative Charles Bass

Lobby Filings

Clients

Firms

Years Active

2017–2022

Total Contributed

$250

Contributions

Recipients

Contrib Filings

Top Recipient Legislators

Legislator	Pty	St	Total
Gus Bilirakis	R	FL	$250

Top Committees / PACs

Payee	Count	Total
BILIRAKIS FOR CONGRESS	1	$250

Lobbying Filings

All 2022 2021 2020 2019 2018 2017

Year	Firm	Client	Income
2022 3rd Quarter - Termination	GLENMARK PHARMACEUTICALS USA	GLENMARK PHARMACEUTICALS USA	—
2022 2nd Quarter - Report	GLENMARK PHARMACEUTICALS USA	GLENMARK PHARMACEUTICALS USA	—
2022 1st Quarter - Report	GLENMARK PHARMACEUTICALS USA	GLENMARK PHARMACEUTICALS USA	—
2021 4th Quarter - Report	GLENMARK PHARMACEUTICALS USA	GLENMARK PHARMACEUTICALS USA	—
2021 3rd Quarter - Report	GLENMARK PHARMACEUTICALS USA	GLENMARK PHARMACEUTICALS USA	—
2021 2nd Quarter - Report	GLENMARK PHARMACEUTICALS USA	GLENMARK PHARMACEUTICALS USA	—
2021 1st Quarter - Report	GLENMARK PHARMACEUTICALS USA	GLENMARK PHARMACEUTICALS USA	—
2020 4th Quarter - Report	GLENMARK PHARMACEUTICALS USA	GLENMARK PHARMACEUTICALS USA	—
2020 3rd Quarter - Report	GLENMARK PHARMACEUTICALS USA	GLENMARK PHARMACEUTICALS USA	—
2020 2nd Quarter - Report	GLENMARK PHARMACEUTICALS USA	GLENMARK PHARMACEUTICALS USA	—

Page 1 of 3 · 25 filings Next

Political Contributions

Recipient / Honoree	Legislator	Payee / Committee	Date	Amount
Gus Bilirakis	Gus Bilirakis (R, FL)	BILIRAKIS FOR CONGRESS	Mar 30, 2018	$250

Contribution Filings (LD-203)

Year	Period	Posted	Status
2022	Year End	Dec 15, 2023	None
2022	Mid Year	Aug 8, 2022	None
2021	Year End	Feb 17, 2022	None
2021	Mid Year	Jul 30, 2021	None
2020	Year End	Jan 21, 2021	None
2020	Mid Year	Jul 30, 2020	None
2019	Year End	Jan 30, 2020	None
2019	Mid Year	Jul 23, 2019	None
2018	Year End	Apr 26, 2019	None
2018	Mid Year	Jul 30, 2018	Active
2017	Year End	Jan 19, 2018	None
2017	Mid Year	Jul 31, 2017	None